Aspen Aerogels (NYSE:ASPN) Given New $25.00 Price Target at Barclays

Aspen Aerogels (NYSE:ASPN) had its price target trimmed by Barclays from $27.00 to $25.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an overweight rating on the construction company’s stock.

Other equities analysts also recently issued research reports about the stock. HC Wainwright reiterated a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. TD Cowen increased their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. Roth Mkm cut their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research report on Friday, November 8th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Thursday, October 31st. Finally, Piper Sandler dropped their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $28.70.

Aspen Aerogels Stock Performance

Shares of Aspen Aerogels stock opened at $15.80 on Tuesday. The business has a 50-day simple moving average of $22.87 and a 200-day simple moving average of $24.74. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46. Aspen Aerogels has a one year low of $8.79 and a one year high of $33.15. The company has a market cap of $1.22 billion, a PE ratio of 1,581.58 and a beta of 2.21.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ASPN. Driehaus Capital Management LLC lifted its position in shares of Aspen Aerogels by 130.4% in the second quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock valued at $51,439,000 after acquiring an additional 1,220,724 shares in the last quarter. American Century Companies Inc. lifted its stake in shares of Aspen Aerogels by 562.3% during the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock worth $18,382,000 after purchasing an additional 654,350 shares during the period. Millennium Management LLC acquired a new position in Aspen Aerogels in the second quarter valued at $9,339,000. Hood River Capital Management LLC lifted its position in Aspen Aerogels by 12.2% during the first quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock worth $58,088,000 after buying an additional 357,895 shares during the period. Finally, Renaissance Technologies LLC acquired a new stake in Aspen Aerogels in the 2nd quarter worth about $8,340,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.